Non-coding small RNA and melanoma

Abstract

Chai Li, Kang Xiaojing. Non-coding small RNA and melanoma[J]. Journal of International Oncology, 2017, 44(7): 541-543.

［1］ Segura MF, Greenwald HS, Hanniford D, et al. MicroRNA and cutaneous melanoma: from discovery to prognosis and therapy［J］. Carcinogenesis, 2012, 33(10): 1823-1832. DOI: 10.1093/carcin/bgs205. ［2］ Xu Y, Brenn T, Brown ER, et al. Differential expression of microRNAs during melanoma progression: miR200c, miR205 and miR211 are downregulated in melanoma and act as tumour suppressors［J］. Br J Cancer, 2012, 106(3): 553-561. DOI: 10.1038/bjc.2011.568. ［3］ Babapoor S, Horwich M, Wu R, et al. microRNA in situ hybridization for miR211 detection as an ancillary test in melanoma diagnosis［J］. Mod Pathol, 2016, 29(5): 461-475. DOI: 10.1038/modpathol.2016.44. ［4］ Errico MC, Felicetti F, Bottero L, et al. The abrogation of the HOXB7/PBX2 complex induces apoptosis in melanoma through the miR221&222cFOS pathway［J］. Int J Cancer, 2013, 133(4): 879-892. DOI: 10.1002/ijc.28097. ［5］ Felli N, Errico MC, Pedini F, et al. AP2α controls the dynamic balance between miR126&126* and miR221&222 during melanoma progression［J］. Oncogene, 2016, 35(23): 3016-3026. DOI: 10.1038/onc.2015.357. ［6］ Liu S, Howell PM, Riker AI. Upregulation of miR182 expression after epigenetic modulation of human melanoma cells［J］. Ann Surg Oncol, 2013, 20(5): 1745-1752. DOI: 10.1245/s1043401224673. ［7］ Huynh C, Segura MF, GazielSovran A, et al. Efficient in vivo microRNA targeting of liver metastasis［J］. Oncogene, 2011, 30(12): 1481-1488. DOI: 10.1038/onc.2010.523. ［8］ Luo C, Tetteh PW, Merz PR, et al. miR137 inhibits the invasion of melanoma cells through downregulation of multiple oncogenic target genes［J］. J Invest Dermatol, 2013, 133(3): 768-775. DOI: 10.1038/jid.2012.357. ［9］ Chan E, Patel R, Nallur S, et al. MicroRNA signatures differentiate melanoma subtypes［J］. Cell Cycle, 2011, 10(11): 1845-1852. DOI: 10.4161/cc.10.11.15777. ［10］ Kanemaru H, Fukushima S, Yamashita J, et al. The circulating microRNA221 level in patients with malignant melanoma as a new tumor marker［J］. J Dermatol Sci, 2011, 61(3): 187-193. DOI: 10.1016/j.jdermsci.2010.12.010. ［11］ Fleming NH, Zhong J, Da Silva IP, et al. Serumbased miRNAs in the prediction and detection of recurrence in melanoma patients［J］. Cancer, 2015, 121(1): 51-59. DOI: 10.1002/cncr.28981. ［12］ Li Z, Yu X, Shen J, et al. MicroRNA dysregulation in uveal melanoma: a new player enters the game［J］. Oncotarget, 2015, 6(7): 45624568. DOI: 10.18632/oncotarget.2923. ［13］ Hatanaka M, Higashi Y, Kawai K, et al. CD147targeted siRNA in A375 malignant melanoma cells induces the phosphorylation of EGFR and downregulates cdc25C and MEK phosphorylation［J］. Oncol Lett, 2016, 11(4): 2424-2428. DOI: 10.3892/ol.2016.4267. ［14］ Song Z, Lin J, Sun Z, et al. RNAimediated downregulation of CDKL1 inhibits growth and colonyformation ability, promotes apoptosis of human melanoma cells［J］. J Dermatol Sci, 2015, 79(1): 57-63. DOI: 10.1016/j.jdermsci.2015.03.020. ［15］ André ND, Silva VA, Watanabe MA, et al. Knockdown of chemokine receptor CXCR4 gene by RNA interference: Effects on the B16F10 melanoma growth［J］. Oncol Rep, 2016, 35(4): 2419-2424. DOI: 10.3892/or.2016.4620. ［16］ Wang X, Jiang C, Fu B, et al. MILI, a PIWI family protein, inhibits melanoma cell migration through methylation of LINE1［J］. Biochem Biophys Res Commun, 2015, 457(4): 514-519. DOI: 10.1016/j.bbrc.2015.01.007. ［17］ Zhang W, Liu H, Yin J, et al. Genetic variants in the PIWIpiRNA pathway gene DCP1A predict melanoma diseasespecific survival［J］. Int J Cancer, 2016, 139(12): 2730-2737. DOI: 10.1002/ijc.30409.

[1]	Wu Minhang, Sun Wenzheng, Yu Qingzhuo, Guo Rong, Ye Hui, Du Ying, Qiu Jin, An Huazhang, Cao Lili.RNF43 inhibits PD-L1 expressionviaβ-catenin in melanoma cells and promotes CD8⁺T cell-mediated anti-tumor immune reaction[J]. Journal of International Oncology, 2023, 50(7): 407-412.
[2]	Hong Anlan, Cao Meng, Wang Yan, Fang Fang.Research progress on lncRNAs as members of ceRNA network in melanoma[J]. Journal of International Oncology, 2022, 49(1): 61-64.
[3]	Du Mingli, Li Guixiang, Wu Wenjuan, Zhao Lei.Application of circulating tumor DNA in targeted therapy and immunotherapy of metastatic melanoma[J]. Journal of International Oncology, 2020, 47(6): 381-384.
[4]	Zhang Ruizhi, Chen Xin, Zhang Peng, Tao Kaixiong.New progress on diagnosis and treatment of anorectal malignant melanoma[J]. Journal of International Oncology, 2020, 47(6): 377-380.
[5]	Jin Lan, Kang Xiaojing.Drug resistance mechanism and treatment strategy for targeted therapy of melanoma[J]. Journal of International Oncology, 2018, 45(7): 444-448.
[6]	Miao Qiuju, Wang Yifei, Xu Xiulian..Molecular targeted therapy in malignant melanoma[J]. Journal of International Oncology, 2018, 45(11): 699-702.
[7]	Xia Dechun, Kang Xiaojing.Role and mechanism of Notch signaling pathway in melanoma growth and metastasis[J]. Journal of International Oncology, 2018, 45(10): 635-638.
[8]	Wang Yanjun, Kang Xiaojing.Biomarkers for malignant melanoma[J]. Journal of International Oncology, 2018, 45(1): 59-.
[9]	Sun Chengyu, Xu Yuqing.Immunotherapy in melanoma patients with autoimmune disease[J]. Journal of International Oncology, 2017, 44(4): 310-312.
[10]	He Yan, Tie Jun, Tang Jun.Role of microphthalmia-associated transcription factor in melanoma metastasis[J]. Journal of International Oncology, 2017, 44(4): 281-283.
[11]	Tang Jianqin, Hou Xiaoyang, Jiang Guan, Wei Zhiping, Liu Yanqun.Application of nanotechnology in the diagnosis and therapy of melanoma[J]. Journal of International Oncology, 2016, 43(11): 871-873.
[12]	MA Ya-Nan, WANG Bao-Hong, SU Qing-Hong, XU Xiao-Qun, WANG Jun-Fu.Effect of miR27a on cell proliferation and apoptosis in human melanoma cell line WM239[J]. Journal of International Oncology, 2015, 42(3): 161-164.
[13]	Liu Zhaoyun.Expression and therapy of Prame gene on hematologic malignancies[J]. Journal of International Oncology, 2014, 41(8): 611-614.
[14]	YANG Wen-Jing, LI Yao-Ping.Clinical reseach progression of anorectal malignant melanoma[J]. Journal of International Oncology, 2013, 40(5): 366-369.
[15]	YANG Meng, KUANG Xiao-Cong, PAN Yan-Bin, DENG .Frequencies of BRAF mutations in clinical Pathology of cutaneous melanoma: a meta-analysis[J]. Journal of International Oncology, 2013, 40(10): 797-800.

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles15

Recommended Articles

Metrics

Comments